Enacted in May 2016
Revised December 16, 2019
Recently revised May 11, 2022
A manuscript submitted for Clinical Ultrasound must satisfy the following requirements. Any matter not specified in these Instructions is governed by the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (http://www.icmje.org).
1. Manuscript Types, Author Qualifications, and Languages
Clinical Ultrasound publishes clinical or experimental research manuscripts (original articles), case reports, reviews, discussions, clinical images, and readers’ letters. Original manuscripts, case studies, clinical images and readers’ letters may be submitted by either clinical doctors or researchers. Reviews and discussions may be submitted at the request of the Publication Committee. A manuscript must be written in Korean or English. A manuscript written in Korean should use the terminology listed in the latest version of the Medical Terminology Database published by the Korean Medical Association. A manuscript written in English may be published as is after a review by the Publication Committee. The Korean Association of Clinical Ultrasound (“KACU”) reserves the copyrights to all manuscripts published in Clinical Ultrasound.
2. Research and Publication Ethics
Clinical Ultrasound follows the research and publication ethics guidelines set forth in the Ethics Guidelines of the Korean Association of Clinical Ultrasound, the Publication Ethics Guidelines for Biomedical Journals (http://kamje.or.kr/publishing_ethics.html), and the Guidelines on Good Publication Practice (https://publicationethics.org/files/u7141/1999pdf13.pdf) of the Committee on Publication Ethics (COPE).
1) Registration of Clinical Trials
A clinical trial or study should be registered with a national clinical trial registry (http://ncrc.cdc.go.kr) or an agency certified by WHO or the International Committee of Medical Journal Editors.
2) Disclosure of Conflicts of Interest
The corresponding author should disclose all information on conflicts of interest that may affect interpretation of the findings, including any financial support from or affiliation with a pharmaceutical company, any political pressure from an interest group, or any academically related issue, to the editors. In particular, any and all financial support used for the research should be clearly disclosed.
3) Written Informed Consent
Copies of written Informed consent from patients and approval from the institutional review board should be retained. As required, an editor or a reviewer may request a copy of written consent or approval to resolve related issues.
4) Requirements Regarding Human and Animal Rights
A study on humans should be consistent with the ethical standards set forth in the Declaration of Helsinki 1975 (revised in 2004). A study on animals including mammals or aves should be approved by the animal experiment ethics committee of the relevant institution, and conducted in accordance with Article 13 of the Animal Protection Act of the Republic of Korea or laboratory regulations equivalent thereto. An experiment plan approved by an animal experimental ethics committee should be available if required and requested by an editor or a reviewer.
5) Author Qualifications
A person listed as an author in a manuscript should satisfy the following requirements: 1) contribution to the basic concepts and design of the study, and analysis and interpretation of the data; 2) significant contribution to writing, revising key parts of, or improving on the manuscript; and consent to the content of the final manuscript. In the event that the number of authors exceeds six, descriptions of the roles of the respective authors should be provided when submitting the manuscript.
6) Originality and Duplicate Publication
A submitted manuscript should be original and may not be considered for simultaneous publication in any other journal. No part of a manuscript may be duplicated in any other journal without permission from the Editorial Committee once its publication is finalized. In the event that a manuscript published on Clinical Ultrasound is confirmed to be duplicated in another journal, that fact will be published in the journal, any institution the authors are affiliated with will be notified, and the author will be subject to a penalty.
7) Secondary Publication
A manuscript may be republished as long as it satisfies the republication requirements set forth in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
8) Copyright Permission
When citing any figure or table from a published article, copyright permission must be obtained from the journal of publication, and a reference to the copyright permission should be included in the manuscript.
3. Process to manage the research and publication misconduct
When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conf licts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the COPE (Committee on Publication Ethics; http://publicationethics.org/resources/flowcharts). The Editorial Board of Clinical Ultrasound will discuss the suspected cases and reach a decision. Clinical Ultrasound will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
4. Review Process
All received manuscripts are reviewed for publication based on research quality, originality, and clinical and scientific significance. In general, a preliminary decision on publication is made within four weeks from receipt, and the reviewers’ opinions are provided using the corresponding author’s email address. A revised manuscript should be resubmitted by the corresponding author online, along with a description of how the manuscript was revised in accordance with the reviewers’ comments. A manuscript should be reviewed by at least two experts, and a reviewer may demand a second or a third review. In the event that a revised manuscript is not submitted within eight weeks from the Editorial Committee’s decision on publication, the manuscript is deemed to have been withdrawn.
Once the journal decides to publish a manuscript, the KACU reserves the copyright on the manuscript, and the manuscript may not be published in another journal without written permission. A copyright release form should be prepared and submitted to the office of the Editorial Committee by fax or mail upon approval of publication.
6. Online Submission Rules
All manuscripts should be submitted to Clinical Ultrasound by logging in at the Clinical Ultrasound online submission website (http://submit.clinicalultrasound.org/) and following the instructions therein. A failure to comply with these rules may result in the return or delayed publication of the manuscript.
2) Research Method-Specific Submission Guidelines
7. Manuscript Preparation
1) Word Processor and Manuscript Format
All manuscripts must be written in Korean or English using plain and concise expressions. Manuscripts should be prepared using Microsoft Word or another major word processor program with a font size of 12 point and double spacing (200%), on A4 or letter size with a 3-cm margin on the top, left, right, and bottom. All pages of the manuscript should be numbered, including the cover. Metric units should be used when preparing a manuscript. The following guidelines apply to the associated research methods in the following table, including randomized controlled studies, diagnostic studies, meta-analyses, observational studies, and non-randomized controlled studies.
8. Original Articles
An original article reports the findings of basic and clinical studies. Even though the length of an original article is not limited, the Editorial Committee may restrict excessive figures or tables. An original article manuscript consists of the following parts: cover page, English abstract and keywords, introduction, subjects and method, findings, discussion, summary, acknowledgements, references, tables, figure descriptions, and figures. When submitting a manuscript, a statement that the manuscript has not been previously published or redundantly submitted to another journal in full or in part should be included. It should also include a statement that the authors’ analysis and manuscript preparation have not been affected by any conflict of interest including any financial support from or affiliation with a pharmaceutical company, any political pressure from an interest group, or any academically related issue.
1) Title Page
The title page should indicate the title of the article, the names of all authors, and their affiliations. The title of the article should consist of the minimum number of words needed, including the keywords, required to communicate the content of the article, and should be less than 30 characters in Korean and 120 characters in English, including spaces. The title should not include abbreviations or acronyms, and the specifics of the experiment animals, if used, should be disclosed in the title. The abbreviated title should not exceed 40 characters, including spaces. In the case of a multiinstitution study written by authors with different affiliations, the institution where the study was mainly conducted will be listed as no. 1, and the other institutions will be presented in numerical order by adding superscript numbers to the names of the relevant authors starting with no. 2. The names, mailing addresses, telephone numbers, fax numbers, and email addresses of the corresponding authors should be provided.
2) English Abstract and Keywords
The abstract of an original article should be written in English and consist of four parts: Background/Aims; Methods; Results; and Conclusions. The abstract should not exceed 250 words. Acronyms should be kept to a minimum and clearly comprehensible. Five or less English keywords should be selected from among indexed words in the Medical Subject Heading (MeSH) of Index Medicus.
The Introduction should briefly describe the background of the study, and mention the findings of articles and researchers closely related to the study. It should also clearly describe the subject matter covered by the study.
The Method should be described briefly, but with sufficient details to allow other researchers to replicate the study. The sources of all and any special chemicals and reagents used for the study should be listed in the following order: manufacturer, city (state), and country. If required, information on institutional review board approval and patient consent should be disclosed. This section should also explain the statistical analysis methods and the criteria for statistical significance.
The Results should be provided in a logical manner using figures and tables. The content of the figures and tables should not overlap.
The Discussion section should briefly describe and discuss the study data and findings. While analogical reasoning is allowed, it should be related to the study findings. The descriptions in the Findings section should not be repeated here.
7) Korean Abstract and Keywords
The Korean abstract should be prepared in the same format as the English abstract, and consist of the Purpose/Aim (목적), Method (방법), Findings (결과), and Conclusions (결론). Five or less Korean keywords should be provided as well.
Acknowledgements may be added to mention persons who made significant contributions to the study but not to the extent to include them as authors. All funding used for the study must be mentioned in the acknowledgments.
When citing references in the main text, they should be numbered in the order of citation with an Arabic number in brackets. The use of cited author names in the main body is not recommended. When this is of absolute necessity, the names of both Korean and foreign authors should be presented in English. For example, for articles with a single author, this should appear as: ‘Kim , Bailey ’; for articles with two or more authors: ‘Park et al. , Brougham et al. .’ In the event that a Korean author provided the bibliography in English, the format for foreign authors should be used. The cited literature should be listed in the References section in the order they appear in the main text. The names of up to six authors may be provided for each article. When there are seven or more authors, the first three authors should be listed followed by ‘et al.’ If a cited article is published online and its issue number and volume number have not been decided, the digital objective identifier (DOI) should be provided. The journal abbreviations in Index Medicus should be used for journal titles, and the NLM Style Guide for Authors, Editors, and Publishers (http://www.nlm.nih.gov/citingmedicine) should be used for any other formats not specified herein.
- 1. Yoo BM, Lehman GA. Update on endoscopic treatment of chronic pancreatitis. Korean J Intern Med 2009;24:169-179.
- 2. Caselli RJ, Dueck AC, Osborne D, et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 2009;361:255-263.
- 3. Gilman AG, Rall TW, Nies AS, Taylor P. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 9th ed. New York: Pergamon Press, 1996.
Part of a book:
- 4. Costa M, Furness JB, Llewellyn-Smith IF. Histochemistry of the enteric nervous system. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 2nd ed. Vol. 1. New York: Raven, 1987:1-40.
- 5. Hong GD. The relationship between low serum cholesterol level and cancer mortality [dissertation]. Seoul (KR): Seoul National University, 2009.
- 6. Rice AS, Brooks JW. Canabinoids and pain. In: Dostorovsky JO, Carr DB, eds. Proceedings of the 10th World Congress on Pain; 2002 Aug 17-22; San Diego, CA. Seattle (WA): IASP Press, 2003:437-468.
- 7. Suzuki S, Kajiyama K, Shibata K, et al. Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? Ann Oncol 2008 Mar 19 [Epub]. https://doi.org/10.1093/annonc/mdn059.
- 8. American Cancer Society. Cancer reference information [Internet]. Atlanta (GA): American Cancer Society, c2009 [cited 2009 Nov 20]. Available from: http://www.cancer.org/docroot/CRI/CRI_0.asp.
- 9. National Cancer Information Center. Cancer incidence [Internet]. Goyang (KR): National Cancer Information Center, c2009 [cited 2009 Oct 20]. Available from: http://www.cancer.go.kr/cms/statics.
9. Case Report
Case reports describing cases that are clinically significant and very rare may be published. A case study should report a topic that is important for medical researchers, and ideally should include illustrations to help readers understand the content. A case study should consist of the following sections: cover page, English abstract, keywords, introduction, case, discussion, summary and Korean keywords, acknowledgements, references, tables, and figures. A case study may not exceed seven authors, and the English abstract should be 150 or fewer words, with no specified format. The combined number of figures and tables may not exceed five, and the number of references is restricted to five.
A review is a discussion focused on a specific topic, and submitted solely at the request of the Publication Committee. A review should consist of the following sections: cover page, English abstract and keywords, introduction, body, conclusions, acknowledgements, references, tables, and figures. The English abstract should be 200 or fewer words, with no specified format. The main text should not exceed 7,500 words including the references, tables, and figures.
A discussion is written about a specific article recently published in Clinical Ultrasound, and the latest knowledge and opinions in the relevant field, at the request of the Publication Committee. A discussion covers topics with new insights and issues actively researched in all areas of clinical ultrasound. Such a submission should not exceed 2,000 words excluding the references, tables, and figures.
12. Clinical Images
A clinical image is a high-quality photograph mainly aimed at education through photography, which may contribute to clinical imaging, pathological findings, and visual findings. The case represented by a clinical image should be of a rare disease or a common disease with irregular patterns. Up to two photographs may be submitted, along with a brief description not exceeding 1/2 of an A4 page including the case symptoms and findings, test results, diagnosis process, and an image description.
13. Reader’s Letter
A reader may submit a reader’s letter to provide constructive criticism or comments regarding a specific article published in the journal, expedite the publication of new medical findings, or briefly describe exceptional yet educational cases. However, the Publication Committee decides whether to publish a reader’s letter. The manuscript for a reader’s letter should consist of the title, main body, keywords, references, tables, and figures without an abstract, and should not exceed a single A4 page. The combined number of figures and tables should not exceed three, and the number of references is restricted to five.
14. Publication Fee and Printing Fee
A publication fee is not required for an original article or a case study. However, the authors should bear the expenses incurred from design, engraving, color printing, or special printing expenses required for the article. A supplement may be made at the authors’ request in 50 copies or more, and the expenses should be borne by the authors. A quotation sheet for supplements may be submitted when sending the proof of the manuscript to the corresponding authors.
15. References for the Instructions
- 1. International Committee of Medical Journal Editor. Uniform Requirements for Manuscripts Submitted to Biomedical Journals:Writing and Editing for Biomedical Publication [Internet]. International Committee of Medical Journal Editor; 1979 [updated 2008 Oct; cited 2009 Nov 1]. Available from: http://www.icmje.org/urm_main.html.
- 2. Dorland WA. Dorland’s Illustrated Medical Dictionary [Internet]. Elsevier; c1898 [updated 2008; cited 2009 Nov 1]. Available from: http://www.dorlands.com.
- 3. Korean Medical Association. English-Korean Korean-English Medical Terminology [Internet]. Seoul (KR): Korean Medical Association; 1977 [updated 2005; cited 2009 Aug 1]. Available from: http://www.kamje.or.kr/term.
- 4. Korean Association of Medical Journal Editors. Good Publication Practice Guidelines for Medical Journals [Internet]. Seoul: Korean Association of Medical Journal Editors; 2008 [cited 2009 Nov 1]. Available from: http://kamje.or.kr/ publishing_ethics.html.
- 5. Committee on Publication Ethics. Guidelines on Good Publication Practice [Internet]. London: Committee on Publication Ethics; 1999 [cited 2009 Nov 1]. Available from: http://publicationethics.org/static/1999/1999pdf13.pdf.
- 6. World Medical Association. Declaration of Helsinki [Internet]. Ferney-Voltaire: World Medical Association; 1964 [updated 2008 Oct; cited 2009 Nov 1]. Available from: http://www.wma.net/e/policy/b3.htm.
- 7. National Library of Medicine (US). MeSH [Internet]. Bethesda (MD): National Library of Medicine (US); 1954 [updated 2009,cited 2009 Nov 1]. Available from: http://www.ncbi.nlm.nih.gov/sites entrez?db=mesh.
- 8. Patrias K. Citing medicine: the NLM style guide for authors, editors, and publishers [Internet]. 2nd ed. Wendling DL, technical editor. Bethesda (MD): National Library of Medicine (US); 2007 [updated 2009 Jan 14; cited 2009 Aug 1]. Available from:http:www.nlm.nih.gov/citingmedicine.